Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 12, 2017 07:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Announce Fiscal Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on September 19, 2017

RANCHO CORDOVA, Calif., Sept. 12, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
September 05, 2017 07:00 ET | Source: Cesca Therapeutics Inc.

CESCA Therapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

RANCHO CORDOVA, Calif., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
August 31, 2017 07:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Participate in the CAR-TCR Summit 2017

RANCHO CORDOVA, Calif., Aug. 31, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
August 24, 2017 11:09 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces International Distribution Agreement With Boyalife WSN Ltd.

RANCHO CORDOVA, Calif., Aug. 24, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
July 28, 2017 07:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Issuance of New Cellular Processing Patent Poised to Revolutionize CAR-T Cell Manufacturing

RANCHO CORDOVA, Calif., July 28, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing, today announced that the U.S. Patent and Trademark...
July 10, 2017 07:45 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Acquires the Cell Processing Systems of SynGen Under Asset Acquisition Agreement

RANCHO CORDOVA, Calif., July 10, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
June 23, 2017 09:59 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Set to Join Russell Microcap® Index

RANCHO CORDOVA, Calif., June 23, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, is...
June 12, 2017 12:59 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Present at the 2017 Marcum MicroCap Conference

RANCHO CORDOVA, Calif., June 12, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies,...
May 18, 2017 08:33 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Present at the Inaugural Cell and Gene Exchange 2017

RANCHO CORDOVA, Calif., May 18, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today...
May 11, 2017 16:15 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Announces Fiscal Third Quarter and Nine Month 2017 Financial and Operating Results and Provides Corporate Update

RANCHO CORDOVA, Calif., May 11, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today...